The Practical Implementation of EU Regulations for Medical Devices and in vitro Diagnostic Medical Devices (Webinar)

In EIPG’s and PIER’s next webinar, John Deavin will review current Medical Device Directives and the timetable for transition to the Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR), the proposed UK system.

This is an event for members of EIPG member organisations, Contact your national association EIPG representative for further information.

You May Also Like

Closing the gap in R&D and looking forward to new models for healthcare

The European effort to improve the competitiveness of the pharmaceutical sector is mainly focused on enhancing attractiveness to achieve the 2030 targets for clinical trials and on reforming the overall legislative framework. Meanwhile, the US has launched an aggressive reform of early development, aimed at tackling the emerging competition from China. At the HLTH 2026 experts agreed that the true challenge for Europe may be implementation, not innovation.

State of the Union (SOTEU) 2026 and other news from EU’s institutions

September brought many developments on open files. The opinion of the Advocate General of the European Court of Justice, still subject to the Court’s final judgement, represents the first position against the current EPR scheme. The JURI Committee of the Parliament approved its position on the SPC extension, supporting the possibility of manufacturing and stockpiling biosimilars in Eu-rope to be ready for day-1 launch. The proposal for a Public Procurement Act introduces quality criteria alongside the sole price criteria.

Consultation open on the revision of GMP’s Chapter 1

Comments on the draft revision of Chapter 1 of the Good Manufacturing Practices must be submitted by 3 December 2025. The revision aims to update this fundamental text in light of the more recent advancements in pharmaceutical manufacturing, so to better ensure the ef-fectiveness and safety of medicinal products. The EIPG will liaise with member associations to submit a joint response to the draft text.